New MHRP pre-clinical SHIV remission study shows progress in delaying viral load rebound
2021-03-01
(Press-News.org) SILVER SPRING, Md. - A recent preclinical study by U.S. Military HIV Research Program (MHRP) researchers showed that an experimental therapy combining a TLR7 agonist and two broadly neutralizing antibodies delayed viral rebound in SHIV-infected macaques after antiretroviral therapy (ART) interruption.
The experimental combination therapy consisted of TLR7 agonist GS-986 and two broadly neutralizing antibodies (bnAbs), N6-LS and PGT121, targeting different regions of the HIV envelope. The rhesus macaques were initiated on viral suppressive antiretroviral therapy 14 days post infection, a timespan from infection to treatment which mirrors what is feasible in acute HIV infection. Researchers then administered the experimental combination therapy, followed by ART pause and measured how long it took for SHIV viral load to rebound.
"This study demonstrated that the combination of TLR7 agonist and dual bnAbs delayed viral rebound after ART interruption by 2-fold," said Dr. Denise Hsu, MHRP Associate Director of Therapeutics. "This approach may represent a potential strategy to target the HIV reservoir in HIV-infected individuals."
A critical barrier to curing HIV is the reservoir of latent virus that remains hidden and infects cells throughout the body, leading to viral rebound in the vast majority of HIV-infected individuals after they discontinue ART. The hypothesis behind this strategy is that an agent such as the TLR7 agonist, bolstered by therapeutic bnAbs, can stimulate the immune system to clear latent HIV. The paper was published in PLOS Pathogens.
MHRP, part of the Walter Reed Army Institute of Research, collaborates with the Thai Red Cross AIDS Research Centre in Bangkok to identify acutely infected individuals and immediately start them on ART in a study called RV254. For the last few years, small clinical trials within this cohort have evaluated strategies aimed at inducing a cure or long-term remission of HIV. Interventions are wide-ranging and include therapeutic HIV vaccines and broadly neutralizing antibodies.
During these studies, volunteers are taken off ART to test the effects of a candidate intervention. This method, called analytical treatment interruption (ATI), looks at the time it takes for the viral load to rebound after the interruption. Participants are followed closely and restart ART when viral load rises to a certain threshold.
According to Dr. Sandhya Vasan, HJF Director for MHRP, "While we have seen some promise in our ATI trials, it has become clear that we need a combination intervention strategy to generate longer lasting viral suppression."
Based on these new preclinical data and building, MHRP hopes to evaluate the combination of innate immune stimulation, active and passive immunization for the induction of HIV remission in early treated people living with HIV.
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009339
INFORMATION:
About MHRP
The U.S. Military HIV Research Program (MHRP), part of the Walter Reed Army Institute of Research, is at the forefront of the battle against HIV/AIDS to protect U.S. troops from infection and reduce the global impact of the disease. MHRP has been recognized as a leader in HIV diagnostics, epidemiology and vaccine research for over three decades and, more recently, has built an international reputation for pioneering discoveries in acute infection and remission. Its research is supported by a cooperative agreement (W81XWH-18-2-0040) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), and the U.S. Department of Defense (DOD). The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army, the Department of Defense, or HJF.
ELSE PRESS RELEASES FROM THIS DATE:
2021-03-01
NEW YORK, NY (March 1, 2021)--By harnessing the immune system against cancer, immunotherapies have revolutionized the way some types of cancer are treated. But most patients--across cancer types--do not respond, and in most cases, scientists are at a loss as to why.
Researchers at Columbia and MIT have created a new technique that can uncover nearly all of the tricks cancer cells use to evade immunotherapies, which could lead to the development of more effective treatments.
The researchers tested their new technique with cancer cells and matching immune cells from melanoma patients and identified previously unknown resistance mechanisms to immune checkpoint ...
2021-03-01
Black Americans have a high level of vaccine hesitancy and mistrust of COVID-19 vaccines, including among Black health care workers, according to a new RAND Corporation survey.
Those who expressed vaccine hesitancy also showed high levels of overall mistrust in the vaccine, concerns about potential harm and side effects, and lack of confidence in vaccine effectiveness and safety.
Participants in the RAND survey reported higher trust in COVID-19 information from health care providers and public health officials than from elected local and federal officials.
The findings are based on a survey ...
2021-03-01
Tissue engineering has long-depended on geometrically static scaffolds seeded with cells in the lab to create new tissues and even organs. The scaffolding material -- usually a biodegradable polymer structure -- is supplied with cells and the cells, if supplied with the right nutrients, then develop into tissue as the underlying scaffold biodegrades. But this model ignores the extraordinarily dynamic morphological processes that underlie the natural development of tissues.
Now, researchers at the END ...
2021-03-01
A team of international researchers led by a Florida State University assistant professor has analyzed reams of data from the Neolithic to Late Roman period looking at migration patterns across the Mediterranean and found that despite evidence of cultural connections, there's little evidence of massive migration across the region.
"Because of the prevailing scholarly attitude of the 'connected' Mediterranean -- one with high degrees of mobility and migration that drive the archaeological patterns we see -- we'd imagined we'd see comparatively high levels of migration reflected in the strontium isotope data," said Thomas Leppard, assistant professor of anthropology at Florida State. "That instead ...
2021-03-01
Invasive alien species, defined as animals and plants that breed and disperse in a landscape beyond their native range, have negative environmental, social, and economic impacts. One example among many is the forage grass genus Brachiaria, originally African and introduced to Brazil to form cattle pasture. It has become a major threat to the survival of native species and biodiversity at several spatial scales.
Complete eradication of invasive species is often impracticable. Attempts to do so have had undesirable consequences and even been damaging because merely withdrawing an invasive ...
2021-03-01
Too much activity in the hippocampus may cause navigation impairments seen in aging adults, according to new research published in JNeurosci.
Spatial navigation is one of the cognitive abilities that declines sharply in old age. Older adults often have difficulty navigating new environments and will choose to stick with familiar ones. Plus, key regions in the brain's navigation circuit are some of the first affected by Alzheimer's disease. In a recent study, Diersch et al. examined the neural mechanism behind this decline in spatial learning.
In the study, younger ...
2021-03-01
A single letter difference in a single gene, inherited from both parents, spells a lifetime of anemia and pain for 20 million people, mostly of African ancestry, worldwide. Sickle cell disease (SCD) causes red blood cells to assume a sickle shape and jam in capillaries, cutting off oxygen to lungs, brain, bones and other organs. Despite the single genetic origin of SCD, each person's disease experience and even life expectancy depend upon where they live, and the social, physical and environmental factors they encounter.
Now, a new review published by Wiley in the journal Advanced Genetics proposes that it is ...
2021-03-01
The rapid loss of variation within species is a hidden biodiversity crisis, according to the authors of a new study looking at how this variation supports essential ecological functions and the benefits nature provides for people.
Published March 1 in Nature Ecology and Evolution, the study highlights the need to better understand and conserve variation within species in order to safeguard nature's contributions to people.
"Biodiversity means more than the number of species, and when we focus on species-level extinctions we are missing part of the story," said corresponding author Eric Palkovacs, professor of ecology and evolutionary biology at UC Santa Cruz. "Intraspecific variation is a neglected aspect of biodiversity, ...
2021-03-01
ITHACA, N.Y. - The expansion of charter schools in the 2000s led to an increase in school segregation and a slight decline in residential segregation, according to new research from Cornell University providing the first national estimates of the diverging trends.
According to the study, the average district to expand charter school enrollment between 2000 and 2010 experienced a 12% increase in white-Black school segregation and a 2% decrease in white-Black residential segregation.
The patterns moved in opposite directions, the research found, because charter ...
2021-03-01
Scientists from the Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago found that a region within the DNA of the cancer-promoting GLI1 gene is directly responsible for regulating this gene's expression. These findings, published in the journal Stem Cells, imply that this region within GLI1 could potentially be targeted as cancer treatment, since turning off GLI1 would interrupt excessive cell division characteristic of cancer.
"From previous research, we know that GLI1 drives the unrelenting cell proliferation that is responsible for many cancers, and that this gene also stimulates its own expression," says co-senior author Philip Iannaccone, MD, PhD, Professor Emeritus at the Manne Research Institute at Lurie Children's and Northwestern ...
LAST 30 PRESS RELEASES:
[Press-News.org] New MHRP pre-clinical SHIV remission study shows progress in delaying viral load rebound
